Literature DB >> 10374956

Long-term CD8+ T cell memory to Sendai virus elicited by DNA vaccination.

Y Chen, E J Usherwood, S L Surman, T L Hogg, D L Woodland.   

Abstract

The capacity of DNA vaccines to prime CD8+ T cells makes them excellent candidates for vaccines that are designed to emphasize cellular immunity. However, the long-term stability of CD8+ T cell memory induced by DNA vaccination is poorly characterized. Here, the quality of CD8+ T cell recall responses in mice was investigated more than 1 year after DNA vaccination with the Sendai virus nucleoprotein gene. Cytotoxic T lymphocyte (CTL) activity specific for both dominant and subdominant epitopes could be recalled readily 1 year after vaccination and the frequencies of CTL precursors specific for both of these epitopes were relatively high. These CTL responded strongly to subsequent Sendai virus infection in terms of their ability to migrate to the lung and to differentiate into effector cells. In addition, the recall response to virus infection, as determined by CTL activity in the lungs and IFN-gamma responses in the spleen, was both faster and greater in magnitude than that in control-immunized mice. Significantly, virus titres were reduced at least 100-fold in the lungs of mice that were immunized more than 1 year before infection, as compared with control mice. These data demonstrate that CD8+ T cell memory elicited by DNA vaccination is functionally relevant and persists for at least 1 year.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374956     DOI: 10.1099/0022-1317-80-6-1393

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Latent antigen vaccination in a model gammaherpesvirus infection.

Authors:  E J Usherwood; K A Ward; M A Blackman; J P Stewart; D L Woodland
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 2.  Cellular immunity and memory to respiratory virus infections.

Authors:  D L Woodland; R J Hogan; W Zhong
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  beta-Glucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen.

Authors:  Jing Wang; Shengfu Dong; Chunhong Liu; Wei Wang; Shuhui Sun; Jianxin Gu; Yuan Wang; Diana Boraschi; Di Qu
Journal:  J Biomed Biotechnol       Date:  2010-06-10

4.  The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response.

Authors:  Gemma Armengol; Lina Maria Ruiz; Sergio Orduz
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

5.  Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.

Authors:  Chao-Chih Wu; Fang-Cih Wu; Yun-Tin Hsu; Yu-Chia Hsiao; Yuh-Cheng Yang; C Allen Chang; Chih-Long Chang
Journal:  Oncotarget       Date:  2017-05-16

Review 6.  DNA vaccine.

Authors:  Zhengrong Cui
Journal:  Adv Genet       Date:  2005       Impact factor: 1.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.